Ledger.Open graph →

SEC Form D · filed January 5, 2022

Evrys Bio, LLC

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

DOYLESTOWN, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Lillian W. Chiang · Doylestown, PAExec · Director Brian W. Pusch · Doylestown, PADirector Richard Whitley · Doylestown, PADirector Thomas Shenk · Doylestown, PAExec · Director Jeffrey A. Yarckin · Dallas, TXDirector Jon A. Pettee · Dallas, TXExec · Director Evan Markegard · San Diego, CADirector Steven W. Holtzman · Doylestown, PADirector Gregory Venn · Denver, COExec · Director Vinod Berchtold · Luxembourg, LuxembourgDirector Tom C. Slocock · Luxembourg, LuxembourgDirector iCapital Luxembourg Strategies GP SARL · Luxembourg, LuxembourgExec · Director Steven W. Holtzman · Doylestown, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗